The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase II factorial design trial of CPT-11 versus PTX versus each combination with S-1 in patients with advanced gastric cancer refractory to S-1: Final results of OGSG0701.
 
Kazuhiro Nishikawa
Honoraria - Ajinomoto; Chugai Pharma; Taiho Pharmaceutical; TERUMO; Tsumura & Co.; Yakult Honsha
Research Funding - Taiho Pharmaceutical (Inst); Yakult Honsha (Inst)
 
Hiroshi Imamura
Honoraria - Ajinomoto; Shionogi; Taiho Pharmaceutical; Yakult Pharmaceutical
Research Funding - Taiho Pharmaceutical (Inst); Yakult Pharmaceutical (Inst)
 
Tomono Kawase
No Relationships to Disclose
 
Masahiro Gotoh
No Relationships to Disclose
 
Yutaka Kimura
No Relationships to Disclose
 
Shugo Ueda
No Relationships to Disclose
 
Jin Matsuyama
No Relationships to Disclose
 
Junji Kawada
No Relationships to Disclose
 
Naotoshi Sugimoto
Research Funding - Daiichi Sankyo (Inst); Lilly (Inst); Roche (Inst); Sanofi (Inst); Sumitomo Group (Inst); Taiho Pharmaceutical (Inst)
 
Junya Fujita
No Relationships to Disclose
 
Takao Tamura
No Relationships to Disclose
 
Norimasa Fukushima
No Relationships to Disclose
 
Daisuke Sakai
No Relationships to Disclose
 
Toshio Shimokawa
No Relationships to Disclose
 
Yukinori Kurokawa
No Relationships to Disclose
 
Taroh Satoh
No Relationships to Disclose
 
Toshimasa Tsujinaka
No Relationships to Disclose
 
Hiroshi Furukawa
No Relationships to Disclose